Angiotensin-converting-enzyme inhibitors have been identified as a risk factor [30,31]; it was highlighted that whilst these medications may not present with a hyponatraemia in the preoperative period, they can predispose patients to developing a POH in combination with surgical stress and fluid balance abnormalities. Here, ACE is linked to progressive osseous heteroplasia.